BLU - BELLUS Health - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BELLUS Health's activity chart (see below) currently has 27 price targets and 29 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 60.07% with an average time for these price targets to be met of 244.31 days.

Most recent stock forecast was given by GREGORY RENZA from RBC on 15-May-2023. First documented stock forecast 30-Sep-2019.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 15-May-2023

$14.75

$0.01 (0.07%)

$14.75

Buy Since 30-Sep-2019

$14.75

$0.01 (0.07%)

Buy Since 13-Dec-2021

$14.75

$0.01 (0.07%)

$15

Buy Since 26-Jun-2020

$20

$5.26 (35.69%)

$20

Show more analysts

Please expand the browser size to see the chart

What is BLU (BELLUS Health) average time for price targets to be met?

On average it took 244.31 days on average for the stock forecasts to be realized with a an average price target met ratio 60.07

Which analyst has the current highest performing score on BLU (BELLUS Health) with a proven track record?

ANDREW FEIN

Which analyst has the most public recommendations on BLU (BELLUS Health)?

Andrew Fein works at HC WAINWRIGHT and has 18 price targets and 21 ratings on BLU

Which analyst is the currently most bullish on BLU (BELLUS Health)?

Andrew Fein with highest potential upside - $5.26

Which analyst is the currently most reserved on BLU (BELLUS Health)?

Dana Flanders with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?